Creatine kinase B suppresses ferroptosis by phosphorylating GPX4 through a moonlighting function

Ke Wu, Meisi Yan, Tong Liu, Zheng Wang, Yuran Duan, Yan Xia, Guimei Ji, Yuli Shen, Lei Wang, Lin Li, Peixiang Zheng, Bofei Dong, Qingang Wu, Liwei Xiao, Xueying Yang, Haochen Shen, Ting Wen, Jingjing Zhang, Jinfeng Yi, Yuhan DengXu Qian, Leina Ma, Jing Fang, Qin Zhou, Zhimin Lu, Daqian Xu

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

Activation of receptor protein kinases is prevalent in various cancers with unknown impact on ferroptosis. Here we demonstrated that AKT activated by insulin-like growth factor 1 receptor signalling phosphorylates creatine kinase B (CKB) T133, reduces metabolic activity of CKB and increases CKB binding to glutathione peroxidase 4 (GPX4). Importantly, CKB acts as a protein kinase and phosphorylates GPX4 S104. This phosphorylation prevents HSC70 binding to GPX4, thereby abrogating the GPX4 degradation regulated by chaperone-mediated autophagy, alleviating ferroptosis and promoting tumour growth in mice. In addition, the levels of GPX4 are positively correlated with the phosphorylation levels of CKB T133 and GPX4 S104 in human hepatocellular carcinoma specimens and associated with poor prognosis of patients with hepatocellular carcinoma. These findings reveal a critical mechanism by which tumour cells counteract ferroptosis by non-metabolic function of CKB-enhanced GPX4 stability and underscore the potential to target the protein kinase activity of CKB for cancer treatment.

Original languageEnglish (US)
Pages (from-to)714-725
Number of pages12
JournalNature cell biology
Volume25
Issue number5
DOIs
StatePublished - May 2023

ASJC Scopus subject areas

  • Cell Biology

Fingerprint

Dive into the research topics of 'Creatine kinase B suppresses ferroptosis by phosphorylating GPX4 through a moonlighting function'. Together they form a unique fingerprint.

Cite this